APA (7th ed.) Citation

FP, P., A, S., KA, S., Z, M., JA, N., LR, B., . . . A, G. (2021). Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. Advanced therapeutics, 4(3), . https://doi.org/10.1002/adtp.202000163

Chicago Style (17th ed.) Citation

FP, Pons-Faudoa, et al. "Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV-challenged Nonhuman Primates." Advanced Therapeutics 4, no. 3 (2021). https://doi.org/10.1002/adtp.202000163.

MLA (9th ed.) Citation

FP, Pons-Faudoa, et al. "Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV-challenged Nonhuman Primates." Advanced Therapeutics, vol. 4, no. 3, 2021, https://doi.org/10.1002/adtp.202000163.